SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Millennium Pharmaceuticals, Inc. (MLNM)
An SI Board Since February 1997
Posts SubjectMarks Bans Symbol
3044 135 0 MLNM
Emcee:  icanpickem Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2319Part 3: <b>VELCADE(R) (bortezomib) for Injection in combination with doceIan@SI-2/20/2005
2318Part 2: <b>MLN2704 in patients with advanced androgen independent metastaIan@SI-2/20/2005
2317Today's PR from MLNM broken down into readable chunks... Millennium AnnouncIan@SI-2/20/2005
2316[Proteasome Inhibition for Atherosclerosis & Hypercholesterolemia] >>tuck-2/18/2005
2315[Velcade in MM patients with renal impairment] >>Cancer. 2005 Feb 2; [Eputuck-2/6/2005
2314Possibly, and even certainly if this were 5 straight sessions within an uptrend.tom pope-2/3/2005
2313Millennium has been pounded for 5 straight sessions. Seems like a bounce is dueD.Lu-2/3/2005
2312Read his messages 2292 and 2293 :-)boronate-2/1/2005
2311Either Erik slept in today or all these results were already known to him. ;-) Ian@SI-2/1/2005
2310Velcade has just been approved for use in Canada, under the same label as that iboronate-1/31/2005
2309Thanks sales. I kinda follow this one. eomfred hayes-1/27/2005
23081/27/05 conference call notes 1.financial review restated 2005 guidance; at lesoftware salesperson-1/27/2005
2307thanks. good to see you here.scaram(o)uche-1/27/2005
2306It is an early stage inhibitor that is more or less suitable for lab use only.boronate-1/27/2005
2305PS-1145, an IKK inhibitor, showed up today in Clinical Cancer Research, showing tuck-1/27/2005
2304UCB certainly beats the hell out of XOMA as a partner. Nice to know people stilnigel bates-1/25/2005
2303Millennium and UCB Pharma Enter Into Agreement to Collaborate on Two BiotherapeuIcebrg-1/25/2005
2302Millennium Pharmaceuticals (MLNM) was downgraded by Lehman Brothers to "undIcebrg-1/12/2005
2301gs: MLNM (IL/N): Revised 2004 est. by $0.01. Maintain 2005 and 2006 ests. 52-Wemopgcw-1/11/2005
2300Millennium Pharmaceuticals "neutral," target price reduced Tuesday, JIcebrg-1/11/2005
2299Thanks, Sales! Rickscaram(o)uche-1/10/2005
22981/10/05 cc q&a 1. any front line revenue in V guidance ‘05? - - modest incrsoftware salesperson-1/10/2005
2297>>SAN FRANCISCO, Jan. 10 /PRNewswire-FirstCall/ -- Millennium Pharmaceutictuck-1/10/2005
2296CAMBRIDGE, Mass., Jan. 6 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, IIcebrg-1/6/2005
2295Drug makers adding X-rays, MRIs to arsenal Imaging may help predict pharmaceuticIcebrg-1/3/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News